|Bid||2.9200 x 1800|
|Ask||2.9600 x 1100|
|Day's Range||2.8800 - 2.9900|
|52 Week Range||2.7600 - 10.9000|
|Beta (5Y Monthly)||-0.64|
|PE Ratio (TTM)||6.14|
|Earnings Date||Nov 10, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||11.67|
Subscribe to Yahoo Finance Plus to view Fair Value for CODX
Market forces rained on the parade of Co-Diagnostics, Inc. ( NASDAQ:CODX ) shareholders today, when the analysts...
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be presenting on December 1, 2022, at the Piper Sandler 34th Annual Healthcare Conference, held November 29-December 31, 2022, in New York City, New York.
Co-Diagnostics ( NASDAQ:CODX ) Third Quarter 2022 Results Key Financial Results Revenue: US$5.09m (down 83% from 3Q...